uptake with no effect on Ca 2ϩ absorption. This intrinsic cellular adaptation provides the sensitive and selective control of distal Mg 2ϩ transport. The distally acting diuretics amiloride and chlorothiazide stimulate Mg 2ϩ uptake in MDCT cells acting through changes in membrane voltage. A number of familial and acquired disorders have been described that emphasize the diversity of cellular controls affecting renal Mg 2ϩ balance. Although it is clear that many influences affect Mg 2ϩ transport within the DCT, the transport processes have not been identified.
I. INTRODUCTION: IMPORTANCE OF THE DISTAL CONVOLUTED TUBULE IN RENAL MAGNESIUM BALANCE
Control of total body magnesium homeostasis principally resides within the nephron segments of the kidney. The proximal tubule reabsorbs 5-15%, the thick ascending limb of the loop of Henle absorbs 70 -80%, and the distal tubule reclaims some 5-10% of the filtered magnesium. Although the distal tubule reabsorbs only 10% of the magnesium filtered through the glomerulus, this amount is significant because it represents 60 -70% of the magnesium delivered to this segment from the loop of Henle. Because there is little magnesium reabsorption beyond the distal tubule in the collecting ducts, the tubule segments comprising this portion of the nephron play an important role in determining the final urinary excretion of magnesium. The purpose of this review is threefold: 1) to convince the reader that the distal tubule plays an important role in controlling renal magnesium conservation (as important as the thick ascending limb); 2) to discuss recent observations on how magnesium is reabsorbed and what controls magnesium transport within the distal tubule; and 3) to indicate some of the unresolved issues that require further investigation. Most of the recent studies involve the use of isolated cell lines which, on balance, represent the intact distal convoluted tubule (DCT).
II. GENERAL CHARACTERISTICS OF MAGNESIUM ABSORPTION IN THE DISTAL TUBULE
Most of our early knowledge concerning magnesium transport in the distal tubule has come from micropuncture and microperfusion studies of the superficial nephron (48, 131, 249, 251, 256, 288, 289, 344) . 1 Micropuncture studies showed that significant amounts of magnesium are absorbed in the distal tubule (19, 92, 93, 248, 252, 254) . The mammalian distal tubule, located between the macula densa and the cortical collecting duct (CCD), comprises a short post-macula densa segment of thick ascending limb, the DCT, the connecting tubule (CNT), and the initial collecting tubule (333) . The micropuncture studies describing distal magnesium absorption may well have included portions of the superficial CNT as well as the DCT. R. J. M. Bindels failed to detect any apical-to-basolateral (absorption) or basolateral-toapical (secretion) magnesium movement in a mixture of rabbit CNT and CCD cells (personal communication). However, there are significant functional differences among the species and segments studied. There is a gradual transition between the DCT and CNT in human and rats, whereas there is a sharp transition in the rabbit (216) . In the rat and human, chlorothiazide-sensitive NaCl cotransport and parathyroid hormone (PTH)-stimulated calcium transport occurs within DCT segments and PTHresponsive Na ϩ /Ca 2ϩ exchange within the CNT (226) . This is in contrast to the rabbit, where thiazide-sensitive NaCl cotransport is found in the DCT but PTH-responsive Na ϩ /Ca 2ϩ exchange is expressed only by CNT cells (10, 32, 264, 329, 330) . The mouse appears to be more like the rat and human because the two transporters are colocalized to DCT cells (108) . Again, the species and segmental differences of magnesium transport have not been studied.
Although significant magnesium reabsorption takes place along the distal tubule, this is normally achieved with little change in tubular magnesium concentration. Luminal magnesium concentration may increase along the distal tubule with increased magnesium delivery, or it may decrease with magnesium restriction (92, 131, 248, 298) . Normally, distal magnesium absorption is fractionally less than that of sodium or calcium (254) . This is commensurate with the fractional urinary excretion of magnesium, normally ϳ3%, whereas the fractional excretion of sodium and calcium is Ͻ1% (250) . The evidence is that net distal magnesium reabsorption is essentially unidirectional because no secretion of magnesium into the lumen has been reported (254) . Because the distal tubule is characterized by a negative transepithelial voltage and a high epithelial resistance, it is concluded that magnesium transport is active and transcellular in nature (165, 289) . This is unlike magnesium transport within the thick ascending limb that occurs passively through the paracellular pathway (249, 289) . Although the micropuncture and microperfusion studies have clearly shown that magnesium is reabsorbed in the superficial distal tubule, little knowledge has been gained concerning the cellular mechanisms of magnesium transport.
III. MAGNESIUM UPTAKE IN ISOLATED DISTAL CELLS
In vivo micropuncture and microperfusion approaches do not allow for study of cellular mechanisms, and in vitro microperfusion studies have not been performed on DCT because of the difficulty in isolating intact segments. Accordingly, isolated immortalized cell lines have been used to study segmental responses.
A. Measurement of Cellular Mg 2؉ Transport
We have used an established cell line representing the DCT to study Mg 2ϩ transport. This cell line (designated MDCT for mouse distal convoluted tubules) was originally isolated from mouse distal tubules and immortalized by Pizzonia et al. (238) . Friedman and Gesek (111, (115) (116) (117) (118) have shown that this cell line exhibits many of the functional properties characteristic of the intact DCT studied in vivo, such as amiloride-inhibitable Na ϩ transport, chlorothiazide-sensitive NaCl cotransport, and PTHand calcitonin-stimulated Ca 2ϩ transport. Accordingly, MDCT cells appear to have many of the properties of the convoluted segment of the intact distal tubule.
Electrolyte transport is usually quantitated by isotopic flux measurements, but an appropriate isotope for Mg 2ϩ is not available ( 28 Mg has a half-life of 21 h). Accordingly, we developed a cell model to assess Mg 2ϩ transport using fluorescent determinations of intracellular free Mg 2ϩ concentration ([Mg 2ϩ ] i ) (75, 253) . Cytosolic free Mg 2ϩ concentration of epithelial cells is on the order of 0.5 mM. This is ϳ1-2% of the total magnesium, the remainder being complexed to various organic and inorganic ligands and chelated within the mitochondria. Using isolated distal cell lines, we have shown that magnesium entry is through specific and regulated magnesium pathways (76, 254). To determine Mg 2ϩ transport, the epithelial cells were first depleted of Mg 2ϩ by incubating in magnesium-free culture media. Subsequently, the cells were placed in solutions containing magnesium and [Mg 2ϩ ] i measured as a function of time (Fig. 1 45 Ca uptake changed in the presence of Mg 2ϩ depletion or the Mg 2ϩ -refill process. These observations suggest that the influx pathway is specific for Mg 2ϩ and not shared by Ca 2ϩ (76, 253) . We used this approach to characterize the cellular mechanisms of Mg 2ϩ uptake in MDCT cells that may shed light on magnesium transport in distal tubule cells.
Many hormonal and nonhormonal factors influence Mg 2ϩ uptake into MDCT cells. Our observations using MDCT cells closely resemble earlier results using micropuncture and microperfusion techniques in intact rat and dog distal tubules (Table 1) . However, little is known about the cellular mechanisms of electrolyte absorption in the DCT from in vivo micropuncture and microperfusion experiments. Accordingly, the use of isolated cells has allowed a greater in-depth study of cellular mecha- ] i and the same external Mg 2ϩ concentration, the more negative the transmembrane voltage, i.e., more hyperpolarized, the higher was the magnesium influx rate (Fig. 2) . Conversely, depolarization of membrane voltage diminishes Mg 2ϩ uptake (70). The dependence of magnesium entry on the driving force induced by the electrochemical gradient indicates that Mg 2ϩ entry may be mediated by an ion channel.
C. Schematic Model of Distal Cellular
Mg 2؉ Transport
With the above information, we are able to speculate on the mechanisms involved in magnesium absorption within the DCT cell (Fig. 3) . Because the transepithelial voltage is normally in the range of 0 to Ϫ30 mV lumen negative, magnesium absorption is active in nature. Distal magnesium absorption is entirely transcellular moving across the DCT cell. Magnesium may move passively into the cell across the luminal membrane driven by a favorable transmembrane voltage. The luminal magnesium concentration is on the order of 0.2-0.7 mM depending on the condition studied, and intracellular free Mg 2ϩ is 0.5 mM so that under some circumstances Mg 2ϩ entry is against an appreciable concentration gradient (76, 253). We speculate that Mg 2ϩ entry is through a unique channel, and this transport is dependent on the transmembrane voltage. The active step in transcellular movement is predicted to be at the basolateral membrane where Mg 2ϩ leaves the cell against both electrical and concentration gradients. The means by which Mg 2ϩ actively moves across the basolateral membrane is unknown. Evidence taken from studies using nonepithelial cells suggest that Na ϩ /Mg 2ϩ exchange may occur, Na ϩ moving back into the cell coupled with Mg 2ϩ exit from the cell into the interstitium (126) . Alternatively, a specific energy-dependent Mg 2ϩ pump may be present analogous to that reported for calcium. Intracellular Mg 2ϩ plays an important role in enzyme functions including the transport ATPases (102, 250) . The ionic transport pumps such as Na , and a substrate (250) . Finally, it is unlikely that intracellular Mg 2ϩ concentration would normally fall to levels that would compromise ATPase activity or Mg 2ϩ -ATP 2Ϫ levels (182, 183) . Because there is no evidence for an enzyme-dependent magnesium pump at the present time, we have elected not to include it in Figure 3 . In this schematic view, the factors that influence transcellular magnesium absorption include alterations of Mg 2ϩ entry across the luminal membrane and changes in Mg 2ϩ exit across the basolateral membrane; both of these steps may be modulated by the transmembrane voltage and concentration gradients across the respective membrane.
The properties of Mg 2ϩ transport in the DCT, to some extent, resemble those described for calcium handling. (192, 264, 330) . These properties of cellular Ca 2ϩ handling are similar to those postulated here for Mg 2ϩ transport, although the presence of a Mg 2ϩ pump and Na ϩ /Mg 2ϩ exchanger remains to be determined. The regulation of distal magnesium reabsorption may share many of the controls identified for calcium conservation but, as reviewed below, Mg 2ϩ transport may be specifically altered by influences not shared with calcium, thus affecting magnesium homeostasis independent of calcium balance.
IV. LOAD DEPENDENCE OF MAGNESIUM ABSORPTION IN THE DISTAL TUBULE
Distal magnesium absorption is load dependent in that an increase in magnesium delivery to the DCT is associated with an increase in magnesium absorption (19, 71, 248, 254) . In one set of studies, rat distal tubules were perfused with solutions containing variable magnesium concentrations, and early and late collections were performed on the same distal tubule. These collection sites were localized in the first 10 -60% of the superficial distal tubule and likely represent DCT rather than connecting tubules or initial collecting ducts (254) . The first studies involved perfusing DCT with solutions containing zero magnesium. No magnesium was detected in early or late collections when the nephrons were perfused with magnesium-free Ringer solutions in either normal animals or hypermagnesemic rats in which plasma magnesium was elevated to increase the concentration gradient from plasma to lumen. These data suggested that magnesium absorption in the distal nephron is unidirectional, i.e., there is no magnesium secretion in the DCT. Net magnesium absorption was observed when the distal tubules were perfused with solutions containing magnesium. Absolute magnesium absorption increased from 1.35 Ϯ 0.35 to 6.5 Ϯ 0.9 pmol⅐min Ϫ1 ⅐mm Ϫ1 as magnesium in the perfusate was increased from 0.5 to 2.5 mM; accordingly, there was about a fivefold increase in magnesium absorption with about a fivefold increase in luminal magnesium concentration (Fig. 4) . PTH increased absolute and fractional magnesium absorption independent of delivery. Increased magnesium delivery due to hypermagnesemia or hypercalcemia resulted in an increase in absolute absorption but a decrease in fractional transport (246, 254) . Other studies were performed where furosemide was used to inhibit loop magnesium absorption, thereby increasing magnesium delivery to the DCT (248) . Absolute magnesium reabsorption increased from 0.6 Ϯ 0.2 to 3.0 Ϯ 1.7 pmol⅐min Ϫ1 ⅐mm Ϫ1 with increased delivery, whereas fractional absorption remained unchanged in these experiments. The basis for the dependence of magnesium absorption on magnesium delivery and luminal magnesium concentration is also observed at the single-cell level (76). Magnesium reabsorption in the DCT is under the control of a number of hormones and altered by a number of influences. However, the dependence of magnesium absorption with magnesium delivery is maintained in the presence of these factors (246, 254) .
V. HORMONAL CONTROL OF MAGNESIUM TRANSPORT IN THE DISTAL CONVOLUTED TUBULE
A. Peptide Hormones
PTH
A large number of hormones stimulate magnesium absorption within the distal tubule ( Table 1) . The first to be described was PTH. Infusion of PTH to thyroparathyroidectomized (TPTXed) animals increased the reabsorption of magnesium and diminished urinary magnesium excretion (204) . Micropuncture studies showed that part of this hormonal action occurred within the distal tubule (19, 131, 254 ). An increase in magnesium conservation was observed even in the face of enhanced magnesium delivery to this segment (248, 252, 254) . The largest changes were observed in TPTXed hamsters where the mean tubular fluid-to-ultrafiltrable magnesium ratio (TF/UF Mg ) at the distal sampling site fell from 0.56 Ϯ 0.08 to 0.33 Ϯ 0.08 after administration of PTH (131) . This was associated with a fall in fractional magnesium excretion from ϳ14 to 3%. De Rouffignac et al. (287) and Bailly and Amiel (16) have shown that PTH and other hormones stimulate magnesium absorption in the rat distal tubule. They used Brattleboro rats with hereditary diabetes insipidus, which lack endogenous ADH, and they infused either glucose or somatostatin to inhibit glucagon secretion. Furthermore, they TPTXed the animals to eliminate circulating PTH and calcitonin. Thus a "hormone-deprived" animal model was created to serve as a basis for evaluating the respective actions of each hormone (287) . Micropuncture studies were then performed to determine the effects of hormone administration; importantly, these studies were all performed with physiological hormone concentrations. Infusion of PTH-(1O34) to hormone-deprived rats led to diminished magnesium and calcium delivery to early and late distal tubule sampling sites (Fig.  5) . These studies clearly demonstrate that PTH enhances magnesium absorption within the distal tubule. Dai and Quamme (75) showed that PTH also stimulates Mg 2ϩ entry in isolated MDCT cells in excess of 30% above control uptake rates. The change in transport was associated with increases in hormone-mediated cAMP formation, suggesting that PTH acts, in part, through protein kinase A signaling pathways (Fig. 6 ).
Calcitonin
Calcitonin infusions have clearly been shown to enhance renal magnesium conservation in the rat (243) . Poujeol et al. (243) infused calcitonin to TPTXed rats and observed a fall in fractional magnesium excretion from 4.1 Ϯ 0.4 to 1.0 Ϯ 0.3%, which they attributed to an increase in magnesium reabsorption in the loop of Henle. However, subsequent studies with the hormone-deprived rat showed that calcitonin markedly stimulated fractional magnesium absorption in the superficial distal tubule as well as the loop (81) . Fractional absorption in the distal tubule increased by 27 Ϯ 6% in this study (Fig. 5) . These micropuncture studies indicate that calcitonin enhances magnesium conservation, in part, by actions within the distal tubule. Calcitonin has been shown to stimulate intracellular cAMP formation and Mg 2ϩ entry in MDCT cells, indicating that the DCT segment of the distal tubule is a target for this hormone (Fig. 6) . Maximal concentra-FIG. 4 . Effect of luminal magnesium on net magnesium absorption in the superficial rat distal tubule. Distal tubules were perfused from the proximal tubule at constant flow rates (25 nl/min) with solutions containing variable MgCl 2 concentrations (0 -4 mM). Magnesium absorption was calculated by comparing the delivery rates at early and late collection sites along the same perfused distal tubule. Magnesium was quantitated by electron microprobe analysis and water absorption with the use of inulin. The results are from thyroparathyroidectomized rats. [Data from Quamme and Dirks (254) .] tions of calcitonin increased Mg 2ϩ uptake by 49 Ϯ 5%, which is greater than that observed for PTH. Again, hormone-stimulated Mg 2ϩ entry rates were associated with increases in intracellular cAMP levels.
Glucagon
Glucagon is a potent renal magnesium-conserving hormone (16). Bailly and Amiel (16) reported that the acute infusion of pharmacological concentrations of glucagon in parathyroid gland-intact rats leads to a rapid fall in fractional magnesium excretion from 16 Ϯ 1 to 9 Ϯ 2% (16). The response to glucagon is even greater in hormone-deprived animals. Bailly et al. (19) showed that fractional magnesium excretion markedly decreased by ϳ50% (from 71.5 Ϯ 8.0 to 39.6 Ϯ 5.7 nmol/min) with glucagon administration in rats deficient in endogenous PTH, calcitonin, glucagon, and antidiuretic hormone. This was attributed to a doubling of absolute reabsorption within both the loop of Henle (increase from 6.5 Ϯ 0.7 to 11.7 Ϯ 0.7 nmol/min) and the distal tubule (increase from 0.85 Ϯ 0.1 to 1.75 Ϯ 0.3 nmol/min). Accordingly, glucagon acts within the loop and distal tubule of the rat.
We have performed studies in isolated MDCT cells to determine the cellular mechanisms of hormonal stimulation of magnesium transport (67). Glucagon maximally increased Mg 2ϩ uptake by ϳ20% (Fig. 6 ). This stimulation was concentration dependent, associated with intracellular cAMP generation, and inhibited by the channel blocker nifedipine. Clearly, of the segments comprising the distal tubule, the evidence from this study indicates that the convoluted portion is involved with glucagon-induced magnesium conservation.
Arginine vasopressin
The actions of arginine vasopressin (AVP) within the DCT are poorly understood (165) . AVP has been shown to be an effective magnesium-conserving hormone in anesthetized and conscious hormone-deprived rats (37, 93, 286) . Micropuncture studies of these animals have shown that AVP actions occur principally within Henle's loop (93) . Elalouf et al. (93) failed to discern any change in fractional magnesium absorption in the superficial distal tubule after physiological administration of AVP (93) . In these studies, Elalouf et al. (93) reported that fractional calcium absorption significantly increased from 42.0 Ϯ 5.8 to 62.8 Ϯ 7.1%, whereas the change in fractional magnesium transport with AVP was not significant although it increased from 45.5 Ϯ 7.8 to 55.3 Ϯ 15.5% (Fig. 5 ). These changes may have been significant if a greater number of tubules were sampled. Costanzo and Windhager (65) did not observe any change in calcium absorption in the microperfused rat distal tubule with administration of AVP. These animals were TPTXed but not hormone deprived as were those used by Elalouf et al. (93) . In both studies, AVP enhanced sodium absorption in the distal tubule. AVP also stimulates Mg 2ϩ entry into MDCT cells in a concentration-dependent fashion that is sensitive to nifedipine (Fig. 6 ). These observations suggest that AVP plays a role in control of magnesium conservation within the DCT (67). Many of the hormones that have been shown to increase magnesium reabsorption in the distal tubule have additive effects (91, 285) . AVP and glucagon are additive, below maximal concentrations, in stimulating Mg 2ϩ uptake into MDCT cells (67). Accordingly, these hormones, and probably others, together orchestrate magnesium reabsorption in the distal tubule. It would be difficult to predict the effects of one hormone on a background of many. This was the rationale for De Rouffignac (285) using hormone-deprived animals in their studies investigating individual hormone effects. The advantage of using isolated MDCT cells is that hormone-mediated signaling pathways may be investigated, which is difficult or impossible to perform with in vivo studies.
Cellular mechanisms of peptide hormone actions
The cellular mechanisms underlying the hormonal actions on distal magnesium absorption are becoming clearer. Morel and co-workers (17, 215) have shown that PTH, calcitonin, and glucagon stimulate receptor-mediated cAMP release in the DCT (45). They also reported that AVP receptors may be present in the DCT, but there were marked species differences in adenylate cyclase responsiveness (217) . There was little AVP-stimulated cAMP release in the DCT of the rabbit and human, intermediate response in the mouse, and greatest in the rat (215) . We have shown that PTH, calcitonin, glucagon, and AVP stimulate Mg 2ϩ uptake into MDCT cells (21, 67, 69; Fig. 6 ). Friedman and Gesek (108, 113, 117) reported that these hormones also stimulate cellular cAMP accumulation. We have demonstrated that an increase in exogenous intracellular cAMP, with 8-bromo-cAMP, or endogenous cAMP formation, with forskolin, increased Mg 2ϩ uptake, whereas inhibition of protein kinase A with R pcAMPS prevented hormone-stimulated uptake (67). Accordingly, receptor-mediated cAMP release and activation of protein kinase A plays a role in hormone-stimulated Mg 2ϩ uptake in MDCT cells. However, it is apparent that other signaling pathways are present for hormone-mediated Mg 2ϩ uptake in MDCT cells. Hormone-stimulated Mg 2ϩ uptake rates do not correlate with the measured intracellular cAMP levels in MDCT cells (38, 107, 138) . Furthermore, phospholipase C inhibition with U-73122 and protein kinase C inhibition with Ro31-8220 abolished PTH-and calcitonin-stimulated Mg 2ϩ uptake (Fig. 7) . This was true for all of the hormones tested: PTH, calcitonin, glucagon, and AVP (67-69; L.-j. Dai, G. Ritchie, D. Kerstan, H. S. Kang, and G. A. Quamme, unpublished observations). We have previously reported that chelerythrine, a putative protein kinase C inhibitor, did not alter hormone-mediated responses (67, 69). However, this agent has recently been shown to have no inhibitory actions on protein kinase C (176). Our evidence indicates that protein kinase C is involved in hormone signaling responses in MDCT cells; however, the isotype(s) of protein kinase C is not known. These hormones do not elicit receptormediated intracellular Ca 2ϩ transients, suggesting that Ca 2ϩ signaling is not involved with the responses (110, 116) . It is well known that multiple receptors can converge on a single G protein, and in many cases a single receptor can activate more than one G protein and thereby modulate multiple intracellular signals (128) . It is evident that cAMP-dependent protein kinase A, phospholipase C, and protein kinase C pathways are necessary for hormone-stimulated Mg 2ϩ entry into MDCT cells. The details of how peptide hormones act on Mg 2ϩ transport in MDCT cells and intact distal tubules are unknown.
These observations of hormone-stimulated Mg 2ϩ entry are somewhat different from those reported for Ca 2ϩ entry into MDCT cells. Friedman and Gesek (108, 113, 117) showed that PTH and calcitonin increased calcium uptake in the DCT through changes in membrane voltage. They provided evidence that receptor-mediated increases in cAMP activate basolateral Cl Ϫ channels resulting in cellular efflux of Cl Ca 2ϩ entry and increases the driving force for Ca 2ϩ movement into the cell which, in turn, is removed across the basolateral membrane into the blood. More recent studies indicate that PTH-mediated stimulation of calcium transport is through intermediary pathways involving activation of both protein kinase A and protein kinase C (107, 144) . PTH and other hormones may also directly act on Ca 2ϩ entry through apical Ca 2ϩ channels and Ca 2ϩ exit through Na ϩ /Ca 2ϩ exchange, again through activation of these kinases (10, 11, 38). Brunette and co-workers (144, 174) have shown that distal luminal vesicles prepared from rabbit tubules pretreated with PTH transport much more calcium than vesicles from untreated tubules, inferring a covalent modification of putative apical Ca 2ϩ channels. Accordingly, PTH and possibly other hormones may have direct actions on Ca 2ϩ entry in addition to their ability to alter the membrane voltage. Further research is required to determine the cellular mechanisms underlying the action of these hormones on distal divalent cation absorption. Interestingly, Friedman and Gesek (108) failed to demonstrate any effect of glucagon and AVP on Ca 2ϩ entry into MDCT cells, although these hormones increased cellular cAMP accumulation (108 transporter (150) . Ca 2ϩ reabsorption is stimulated by peptide hormones such as PTH and AVP (32). It has been reported that Ca 2ϩ transport is stimulated by hormonemediated signaling pathways that are independent of cAMP but involve a chelerythrine-inhibitable protein kinase C that is not downregulated after chronic phorbol ester treatment (31, 146, 155, 331) . Our studies have shown that both cAMP-protein kinase A and protein kinase C (not sensitive to chelerythrine) are essential in hormonal action within the MDCT cells. Accordingly, hormone signaling within the two segments is qualitatively different. The differential control of calcium reabsorption within the DCT and CCD and magnesium transport in the DCT provides a unique mechanism to differentially regulate renal calcium and magnesium balance.
B. Steroid Hormones

Mineralocorticoid hormones
Mineralocorticoid receptors are present in DCT cells, which are thought to be involved in expression of NaCl cotransport, Na ϩ conductance, and sodium pump activity (57, 283, 333) . The effects of aldosterone on distal tubule magnesium absorption have not been studied with micropuncture techniques. Clearance studies have shown that chronic aldosterone administration results in renal magnesium wasting, but this has been explained by extracellular volume expansion leading to diminished NaCl and magnesium reabsorption within the loop (202, 203, 319) . We have studied the effects of aldosterone on Mg may enhance hormone-stimulated Mg 2ϩ entry by increasing cAMP and its responses. This notion is supported by the observations of others (155) . Rajerison et al. (259) demonstrated that adrenalectomy reduced AVP-stimulated adenylate cyclase activity in membrane fractions prepared from rat kidney medulla. Doucet and co-workers (85, 95) have shown that glucagon-and AVP-responsive cAMP generation is diminished in thick ascending limb and collecting tubule segments harvested from adrenalectomized rats compared with animals treated with physiological doses of aldosterone. These investigators postulate that aldosterone induces a protein(s) that stimulates hormone-sensitive adenylate cyclase activity. Studies with kidney membrane fractions and isolated segments in the absence of aldosterone demonstrated an impairment of coupling between hormone receptors and adenylate cyclase catalytic units that was responsible for diminished cAMP generation (95) . Steroid hormones have significant effects on expression and posttranslational targeting of heterotrimeric G proteins so that associated channels are covalently modified (218, 281, 293) . The mechanism(s) through which steroids control G␣ S proteins (synthesis and/or degradation vs. activity of each unit) associated with Mg 2ϩ uptake in MDCT cells is not known (85) . The role of mineralocorticoids in the physiological maintenance of renal magnesium handling also requires further research.
Vitamin D 3 metabolites
Vitamin D 3 metabolites have important effects on mineral metabolism by 1,25(OH) 2 D 3 actions on epithelial transport. Although it is clear that 1,25(OH) 2 D 3 increases calcium and magnesium absorption within the intestine, its actions within the kidney are unclear (172, 332) . The 1,25(OH) 2 D 3 -dependent calcium binding proteins, calbindin-D 9K and calbindin-D 28K , have long been thought to be involved in facilitating calcium transport across epithelial cells (100, 172, 332) . The mechanisms of calcium stimulation are obscure, but because of its close association with the basolateral membrane, it is postulated that they somehow increase the calcium pump (Ca 2ϩ -Mg 2ϩ -ATPase) activity (33, 36, 172) . Within the kidney, calbindin-D is localized in the distal tubule where a significant portion of calcium and magnesium is reabsorbed (187, 197, 284, 316, 324) . The distal tubule, including the convoluted segment, also possesses 1,25(OH) 2 D 3 receptors (186, 187, 284) . Accordingly, 1,25(OH) 2 D 3 and perhaps its dependent calbindin-D may have significant actions within the DCT. The effects of 1,25(OH) 2 D 3 and calbindins on magnesium transport are unknown. Calbindin-D 9K has a relatively high affinity for Mg 2ϩ (6, 49, 185) , and it is appropriately altered by changes in magnesium balance (137) , suggesting a role for these binding proteins in renal magnesium control. (109) . These workers reported that 1,25(OH) 2 D 3 did not alter basal Ca 2ϩ uptake but accelerated PTH-dependent calcium entry rates. This response was rapid, concentration dependent, significant at 2 h and maximal by 5 h, and mediated by transcriptional processes because it was inhibited by cycloheximide (109) . The reasons for the discrepancies between these two reports are not known; it may be the cell type used in the two separate studies or the techniques by which calcium transport was measured. Nevertheless, it is clear that 1,25(OH) 2 D 3 increases calcium-binding protein in distal tubules and suggests that it may have significant actions on basal or hormone-mediated calcium transport.
Lui et al. (186) 9 ). These studies show that vitamin D 3 metabolites modulate magnesium transport in the DCT.
Vitamin D 3 administration has often been associated with increases in urinary magnesium and calcium excretion. Vitamin D 3 metabolites increase intestinal absorption of magnesium and calcium so that a positive divalent cation balance may lead to hypermagnesemia and hypercalcemia and increased divalent cation urinary excretion over time. Vitamin D 3 induces hypermagnesemia and hypercalcemia that diminishes magnesium absorption in the loop of Henle (254) 
C. Prostaglandins
PGE 2 is the major arachidonate metabolite synthesized by cyclooxygenase in the mammalian kidney. PGE 2 has a number of diverse actions on the kidney in addition to its ability to influence renal hemodynamics. PGE 2 inhibits NaCl absorption within the thick ascending limb (313) and modulates sodium and water transport in the CCD (134, 135) . On balance, prostaglandins are thought to be natriuretic by way of their actions on the thick ascending limb and CCD (18, 313). Three clearance studies concluded that arachidonic acid metabolites inhibit tubular reabsorption of calcium and magnesium resulting in increased urinary excretion (106, 282, 295) . Schneider et al. (295) infused PGE 2 into dog renal arteries and showed that calcium and magnesium excretion increased in association with a rise in urinary sodium excretion. Roman et al. (282) and Friedlander and Amiel (106) reported that meclofenamate or indomethacin infusion in rats decreased fractional magnesium excretion by ϳ40%. Again, the changes in urinary magnesium and calcium were associated with similar changes in sodium excretion. Because PGE 2 inhibits NaCl absorption in the thick ascending limb, it may be expected that prostaglandins would increase calcium and magnesium excretion through diminished reabsorption in the loop (342) . However, van Baal et al. (330) have shown that PGE 2 stimulated calcium reabsorption in the rabbit CCD segment of the distal tubule. They reported that PGE 2 stimulated net apical-to-basolateral calcium transport in CCD cells grown to confluence on permeable supports. PGE 2 also stimulated cAMP formation in these cells, initially suggesting that protein kinase A-dependent pathways were involved (249) . However, in a later preliminary report, these investigators reported that the changes in PGE 2 -stimulated calcium transport were not directly associated with cAMP formation so that other signaling pathways may be present in rabbit CCD cells (146 (313) and CCD (107, 155, 244) and AVP-stimulated water transport in the CCD (134) . EP 2 and EP 4 subtypes are coupled to adenylate cyclase that upon stimulation enhances transepithelial calcium transport in the rabbit CCD (329) . Moreover, these receptors may be colocalized to the same cell type but polarized to apical or basolateral membranes (135, 213, 329) . Van Baal et al. (329) have shown that apical and basolateral PGE 2 stimulate calcium absorption through EP 2 and/or EP 4 receptors, whereas activation of basolateral EP 3 receptors inhibits basal and hormone-stimulated calcium transport. We have shown that PGE 2 is a potent stimulator of Mg 2ϩ uptake into MDCT cells (69). These actions are, in part, through cAMP-mediated mechanisms, but we were unable to determine the polarization of receptors because the immortalized MDCT cells used do not form tight junctions and are unlikely to be polarized (110) . Accordingly, it is not known if the PGE 2 effects in the DCT are due to luminal or basolateral prostaglandin. We infer from these results with MDCT cells that prostaglandins may 
D. Insulin
Insulin has clearly been shown to have antinatriuretic and antimagnesiuric effects by its actions on the thick ascending limb of the loop of Henle (78, 79, 153, 163, 195) . Among the tubular segments studied, insulin receptor binding is highest along the thick ascending limb and DCT so that by inference insulin may affect electrolyte transport within the DCT as well as the loop (52, 101, 105, 221) . Insulin also stimulates sodium transport in A 6 cells, which are a distal cell line from Xenopus laevis that have properties similar to the mammalian distal nephron (143, 205, 262) . Insulin-stimulated sodium transport was partly inhibited by genistein, indicating tyrosine kinase was important but was independent on cAMP levels (262). Insulin did not increase cAMP formation in A 6 cells, nor did adenylate cyclase inhibition diminish transport (205, 276) . Because genistein did not completely inhibit insulin actions, Rodriguez-Commes et al. (276) suggested that parallel non-tyrosine kinase-dependent pathways were also involved. They showed that insulin actions in A 6 cells required intracellular Ca 2ϩ signaling, suggesting to these investigators that protein kinase C is needed for some of the responses. Clearly, the insulin-receptor signaling pathways are different in the various cell types studied. We (Fig. 10) . Mandon et al. (195) have explained this potentiation of insulin with other peptide hormones as interactions at different sites along the established hormone-adenylate cyclase signaling system. The actions of insulin-mediated effects on peptides hormone responses are complicated because aldosterone had no effect on insulin actions but potentiated PTH-stimulated cAMP and Mg 2ϩ uptake (77). Although the intracellular mechanisms are unclear, we infer from these studies that insulin plays a singular role in control of magnesium conservation and modulates hormonal regulation of magnesium transport within the distal tubule.
E. Other Hormones and Factors
␣-and ␤-adrenergic agonists
The nephron is richly innervated along its length from the glomerulus to the collecting tubule (22). Renal nerve stimulation significantly increases NaCl and water reabsorption in the proximal tubule, loop of Henle, and distal tubule (83, 113) . Renal nerves also mediate calcium reabsorption through ␣-adrenergic receptors (14). Gesek (113) has reported that MDCT cells possess ␣ 2 -adrenergic receptors, and epinephrine or B-HT 933, an ␣ 2 -agonist, stimulates Na ϩ uptake and Na ϩ -K ϩ -ATPase activity in this cell line. This response was dependent on protein kinase C activity and was associated with increases in phospholipase C and inositol 1,4,5-trisphosphate and diacylglycerol, but ␣ 2 -agonists had no effect on basal or hormonestimulated cAMP accumulation (113, 114) . These findings are consistent with a pertussis toxin-insensitive mechanism. Interestingly, Gesek (113) (119) . We infer from these studies with MDCT cells that renal nerves and circulating catecholamines may play a role in control of magnesium transport in the distal tubule.
Other endocrine and paracrine factors
In addition to the hormones indicated above, others may be involved in regulation of magnesium reabsorption within the DCT including kinins and growth factors (239) . Hoenderop et al. (147) have reported that adenosine increases Ca 2ϩ reabsorption in rabbit CNT and CCD cells. Adenosine responses were through A 1 receptor-mediated pathways involving activation of phospholipase C. Stimulation of Ca 2ϩ transport was independent of cAMP and protein kinase C activity, suggesting that an additional unidentified signaling pathway may be involved in adenosine responses. Based on these observations, we tested whether adenosine stimulates Mg 2ϩ uptake in MDCT cells. Adenosine did not have any effect on Mg 2ϩ increase in MDCT cells but stimulated cAMP formation, indicating the presence of A 2 receptors acting through G s coupling. There was no evidence for A 1 receptors in this cell line. Additionally, DCT cells, including MDCT cells, have P 2 purinogenic receptors that modulate distal hormone-sensitive calcium transport (167) . Finally, ANP receptors are present in the DCT and MDCT cells, but the effects on magnesium transport have not been studied (Dai et al., unpublished observations). ANP stimulates calcium reabsorption in rabbit CCD through cGMP-dependent protein kinase type III (148).
F. Hormonal Regulation and Renal Mg 2؉ Handling
Micropuncture and microperfusion studies and experiments with isolated cells have shown that many hormones regulate magnesium absorption in the distal tubule. Interestingly, with the exception of prostaglandins, all of these hormones and factors also increase magnesium transport in the thick ascending limb of the loop of Henle (285) . Accordingly, these hormone-mediated responses are serially organized to similarly regulate magnesium absorption in both the loop and distal tubule. This organization may be of benefit because influences acting in either the loop or distal tubule may be modified by changes in the other segment.
The interactions of the various peptide and steroid hormones, prostaglandins, and renal innervations are complex (251, 285) . It can be inferred that overall distal magnesium absorption is controlled by all of these influences initiated individually but coming together through shared intracellular signaling pathways. Few studies have been directed at describing these interactions. Clearly, control of renal magnesium handling is important enough to warrant multiple hormonal control.
VI. EXTRACELLULAR CALCIUM/MAGNESIUM-SENSING RECEPTORS IN THE DISTAL CONVOLUTED TUBULE
An extracellular Ca 2ϩ /Mg 2ϩ -sensing receptor has recently been shown to be expressed along the entire length of the nephron, particularly the loop of Henle, DCT, and inner medullary collecting duct (267, 268, 349) . This receptor is very similar to the one expressed in the parathyroid gland (44, 45). It comprises three major domains: 1) a large extracellular amino-terminal domain consisting of 613 amino acids, which is thought to possess cationic binding sites; 2) a 250-amino acid domain with 7 predicted membrane-spanning segments characteristic of the G protein-coupled receptor family; and 3) a carboxy-terminal domain of 222 amino acids that likely resides in the cytoplasm and is involved with intracellular signaling processes (44). The evidence is that elevated plasma Ca 2ϩ or Mg 2ϩ binds to the extracellular domain of the receptor and initiates a number of intracellular signals. Among these is stimulation of G␣ i proteins that modulate adenylate cyclase activity and cAMP levels and G␣ q proteins that activate phospholipase C releasing inositol 1,4,5-trisphosphate and cytosolic Ca 2ϩ (44). Hebert and co-workers (136, 292, 336) postulate that elevated plasma calcium or magnesium and activation of the Ca 2ϩ /Mg 2ϩ -sensing receptor leads to diminished salt (sodium, calcium and magnesium) transport within the loop and water absorption within the inner medullary collecting duct. This results in an increase in urinary water flow in addition to calcium and magnesium excretion, minimizing the opportunity of stone formation. Riccardi et al. (266) , or Ca 2ϩ , abolished PTH-, calcitonin-, glucagon-, and AVP-stimulated cAMP accumulation (Fig. 11) Figure 12 illustrates the effect of neomycin, a polyvalent cation, on PTH-mediated cAMP formation and Mg 2ϩ entry. Accordingly, hormonemediated Mg 2ϩ uptake is dependent on the prevailing extracellular cation concentrations. To test this notion, we determined the magnesium concentration dependence of Mg 2ϩ uptake rates with and without glucagon (Fig. 13 ). Glucagon stimulated Mg 2ϩ uptake in MDCT cells at extracellular Mg 2ϩ concentrations below ϳ1.5 mM; concentrations above these levels lead to inhibition of hormonemediated transport. These recent observations with established cell lines are consistent with earlier micropuncture and microperfusion studies of intact distal tubules. Le Grimellec et al. (177, 178) reported that distal magnesium delivery was significantly enhanced along the distal tubule of hypercalcemic and hypermagnesemic parathyroid gland-intact rats, inferring that magnesium reabsorption is diminished with elevation of extracellular Ca 2ϩ and Mg 2ϩ concentrations. We perfused superficial distal tubules of TPTXed rats with buffer solutions containing variable calcium and magnesium concentrations. As indicated above, net calcium and magnesium reabsorption was dependent on electrolyte delivery to this segment as the fractional reabsorption remained constant at 59 Ϯ 3 and 34 Ϯ 5%, respectively (248, 252, 254) . However, when these studies were performed on hypermagnesemic (plasma magnesium, 3.6 Ϯ 0.2 mM) and hypercalcemic (plasma calcium, 4.2 Ϯ 0.04 mM) rats, the fractional absorption of magnesium was significantly decreased 6 Ϯ 3 and 14 Ϯ 7%, respectively (246, 254) . Similar findings were observed with calcium absorption in the distal tubule (246, 254) . It is apparent from these studies that plasma Mg 2ϩ and Ca 2ϩ control distal absorption of both calcium and magnesium. Our initial studies also showed that significant elevation of luminal magnesium concentration is also associated with diminished fractional magnesium absorption, 24 Ϯ 2% (see elevated luminal Mg 2ϩ concentrations of Fig. 4 may also inhibit adrenocorticoid responses at the transcriptional level. Actinomycin and cycloheximide, inhibitors of protein synthesis, abolish aldosterone potentiation of PTH-stimulated cAMP release and Mg 2ϩ uptake, providing evidence for transcriptional involvement. The prominent mechanism of steroids, which operate through nuclear receptors, is to control transcriptional regulation, expression, and posttranslational targeting of heterotrimeric G proteins (218) . Changes in the levels of expression of G protein subunits in adrenalectomized animals reflect changes in subunit mRNA, suggesting that adrenocorticoids activate genes encoding G␣ s , G␣ i , G␤, G␥, and phospolipase C (PLC)-␤. Adrenal steroids may also increase adenylate cyclase signaling, in the absence of changes in G␣ s , and G␣ i , suggesting regulation of the expression of the adenylate cyclase itself (218 
VII. INTRINSIC CONTROL OF MAGNESIUM TRANSPORT IN THE DISTAL CONVOLUTED TUBULE
In addition to hormone and Mg 2ϩ /Ca 2ϩ -sensing receptor controls described in sections V and VI, the distal tubule is able to regulate Mg 2ϩ uptake in response to diminished extracellular magnesium (298) . Dietary magnesium restriction or intestinal magnesium malabsorption is associated with enhanced renal magnesium reabsorption and decreased magnesium excretion (89, 250, 302) . Micropuncture studies showed that the increase in magnesium conservation was due to enhanced reabsorption within the distal tubule (252, 298) . Distal calcium and sodium reabsorption were not affected. Isolated distal tubule cells, either Madin-Darby canine kidney (MDCK) or MDCT, cultured in magnesium-free media increase their Mg 2ϩ transport rate as determined by microfluorescence. This response is rapid (within 1-2 h) and specific for magnesium because there was no effect on sodium or calcium transport (76, 253). The "adaptation" of magnesium transport rates is intrinsic because there were no hormones in the culture media (Fig. 1) . Furthermore, the adaptation was dependent on the concentration of media magnesium and the length of time in the culture media. Pretreatment of the MDCT cells with cycloheximide inhibited this adaptation by ϳ50% (unpublished observations). Accordingly, it was concluded that magnesium transport is controlled by gene(s) that somehow respond to extracellular magnesium. Other genetically controlled mechanisms involved in intrinsic regulation of magnesium uptake remain to be identified. PCR-differential display identified one gene (termed the magnesium-responsive gene, MRG) that was upregulated by Mg 2ϩ depletion (271 (250) . We postulate that this intrinsic adaptation provides the discriminatory control of magnesium transport independent of sodium and calcium. Intrinsic adaptation provides the selective control that hormonal regulation does not have.
VIII. DISTAL DIURETICS THAT ENHANCE MAGNESIUM ABSORPTION IN THE DISTAL CONVOLUTED TUBULE
A. Amiloride
A large number of clinical studies have led to the notion that amiloride possesses magnesium-conserving properties in addition to its natriuretic and potassiumsparing effects (48, 251, 340). Despite these observations, very few experimental studies have been published concerning amiloride effects on renal magnesium handling. Devane and Ryan (81) have shown that infusion of amiloride reduced the fractional excretion of magnesium in anesthetized rats, which they attributed to a direct renal action of the drug (81). The nephron segments and cellular mechanisms were not delineated in this study.
We (Fig. 15) . These findings provide the basis for both clinical and experimental observations that show that amiloride has magnesium-conserving properties (50, 81, 220, 339) .
B. Chlorothiazide
A number of experimental studies have suggested that acute administration of chlorothiazide decreases urinary magnesium excretion relative to the diuretic effects of increased sodium excretion. Duarte (86) acutely administered chlorothiazide to parathyroid-intact dogs undergoing a diuresis. Fractional excretion of sodium (FE Na ) markedly increased from 1.3 to 7.9%, but the fractional excretion of magnesium (FE Mg ) remained unchanged, 7.3%, after chlorothiazide administration. In these studies, fractional calcium excretion (FE Ca ) increased from 1.5 to 3.1%. Relative to the FE Na , magnesium excretion fell sixfold from 5.6 to 0.9, and calcium excretion decreased from 1.2 to 0.4 after chlorothiazide administration. Eknoyan et al. (90) confirmed these studies and attributed the observation of marked natriuresis and modest magnesiuria and calciuria to the differential reabsorption of these cations in the loop and distal tubule. These studies suggest that chlorothiazide may increase tubular reabsorption of magnesium relative to the natriuretic effects. We performed clearance and micropuncture studies in TPTXed dogs (257) . The acute administration of chlorothiazide resulted in a relatively greater increase in FE Na from 0.5 to 5.6% than calcium (FE Ca /FE Na increased from 1.3 to 1.9) or magnesium (FE Mg /FE Na fell from 1. 4 to 1.3). Similar results were also observed in TPTXed hamsters, where FE Na increased from 1.0 to 3.4% while FE Ca /FE Na decreased from 22.7 to 5.0 and FE Mg /FE Na fell from 19.3 to 5.0 (347) . Micropuncture experiments demonstrated that this action occurred along the distal tubule. Micropuncture studies of the hamster have also shown that chlorothiazide increases magnesium reabsorption relative to sodium in the distal tubule (345) . Accordingly, the acute administration of chlorothiazide produces a significant natriuresis together with little or no change in urinary calcium or magnesium excretion. The results of these studies clearly demonstrate a divergence of sodium absorption with calcium and magnesium transport within the DCT.
Studies with isolated MDCT cells have shown that chlorothiazide increases Mg 2ϩ uptake in a dose-dependent fashion. Maximal concentrations (10 Ϫ4 M) of chlorothiazide increased Mg 2ϩ transport by 58% (70). This was associated with hyperpolarization of the plasma membrane voltage from Ϫ65 Ϯ 5 to Ϫ80 Ϯ 5 mV. Inhibition of Na ϩ -Cl Ϫ cotransport leading to diminished intracellular sodium and chloride concentration results in hyperpolarization of the apical membrane of the DCT (67, 316, 329) and MDCT cells (115) . An increase in the membrane voltage enhances Mg 2ϩ uptake into MDCT cells (Fig. 2) . Accordingly, chlorothiazide appears to stimulate Mg 2ϩ transport through changes in the membrane voltage similar to that seen with amiloride. These studies with MDCT cells demonstrate that chlorothiazide enhances Mg 2ϩ entry in DCT cells that may be translated into an increase in magnesium reabsorption and diminished urinary magnesium excretion.
IX. FAMILIAL DISORDERS AFFECTING DISTAL MAGNESIUM TRANSPORT
Familial diseases, resulting from single gene mutations, are interesting because they demonstrate the phenotypic diversity of transport physiology (Table 2) . Moreover, the variation of genetic diseases suggests ways of magnesium transport that have not been heretofore envisioned. An example of the application of genetic studies to the clarification of our understanding of renal magnesium handling is the recent investigations of the familal disease "hypomagnesemia associated with hypercalciuria and nephrocalcinosis" (HHN). This disease is an autosomal recessive disorder that presents early in childhood. It is characterized by severe renal magnesium wasting resulting in persistent hypomagnesemia and marked hypercalciuria leading to nephrocalcinosis (198, 212, 223, 224, 269, 325, 328) . Through linkage studies, Simon et al. (308) have identified the gene responsible for this disease. This gene termed "paracellin-1" or "claudin 16" encodes a protein of 305 amino acids that is a member of the claudin family comprising proteins such as occludins that form (308) propose that claudin 16 is the protein involved in controlling magnesium and calcium permeability of the cortical thick ascending limb. Mutations in this gene presumably result in abnormal permeability of the paracellular pathway leading to decreased magnesium and calcium reabsorption. These studies explain the earlier microperfusion data of Mandon et al. (197) , who demonstrated that magnesium absorption within the cortical thick ascending limb was passive and paracellular in nature so that it is influenced by transepithelial voltage and the permeability of the paracellular pathway. The permeability of the paracellular pathway is presumably determined by electrostatic charges of proteins comprising this route (255) . De Rouffignac and coworkers (84, 285) have postulated that these paracellular charge complexes may be influenced by hormones that regulate magnesium absorption. Accordingly, genetic diseases involving defective claudin 16 expression are associated with diminished magnesium absorption. The recent work of Simon et al. (308) is a good example of the use of genetic studies in addressing constitutive and congenital disturbances of magnesium metabolism to further our understanding of the physiology of cellular magnesium transport. These investigations may also lead to other avenues of research. Claudin 16 comprises the paracellular pathway of the medullary thick ascending limb and the DCT, but no magnesium is absorbed through the paracellular pathways in these segments. It remains to be determined what physiological role, if any, this protein plays in these segments. Finally, these observations led to speculation of other proteins that may play a role in paracellular magnesium absorption.
A. Hypomagnesemia Associated With Abnormal Renal NaCl Transport
Gitelman syndrome and Bartter syndrome are two autosomal recessive disorders of renal electrolyte transport that have been associated with hypokalemia due to renal potassium loss, chloride-resistant metabolic alkalosis, and elevated plasma renin and aldosterone levels but normal blood pressure (24, 124). The cellular basis for Gitelman and Bartter syndromes is diminished NaCl absorption in the distal tubule and Henle's loop, respectively (307) . Renal magnesium wasting and hypomagnesemia is a distinctive characteristic of Gitelman syndrome, whereas it is not a common feature of Bartter syndrome (30, 124, 278) .
Bartter syndrome can be distinguished from Gitelman syndrome on the basis of the clinical presentation and biochemical profile (28, 29, 30, 160, 290, 311, 320, 
-328). Patients with infantile
Bartter syndrome characteristically present in infancy with a urinary concentrating defect, polyhydramnios, failure to thrive, and fasting hypercalciuria leading to medullary nephrocalcinosis (80, 280, 338) . Those with classic Bartter syndrome present later in childhood with features of water and salt depletion, including polydipsia, polyuria, and episodes of dehydration. Bartter syndrome patients fail to respond normally to furosemide, suggesting to investigators that this disease was due to defective loop function (123, 164, 166, 280, 297) . Using family linkage studies, Simon and co-workers (304 -306) delineated three genetic defects that form the basis for distinguishing three distinct physiological phenotypes in these patients (Table 3) . Type I Bartter syndrome is due to defective Na ϩ -K ϩ -Cl Ϫ cotransport (NKCC2 gene) and characterized by severe hypokalemia in addition to the above (305) . Type II Bartter syndrome is associated with mutations in a potassium channel (ROMK gene, 30-pS K ϩ channel) activity (305) . Because this K ϩ channel is involved in potassium secretion in the CCD, hypokalemia is less severe in this form of the disease. The type III Bartter syndrome is based on a mutation of the basolateral membrane chloride channel (ClCNKB) (306) . Like type I patients, type III patients have severe hypokalemia, but unlike type I and type II phenotypes, type III patients usually have normal calcium excretion, and nephrocalcinosis is not observed. It has been suggested that up to 30% of Bartter patients may have hypomagnesemia due to renal magnesium wasting (173, 297) . However, it is clear that some of these cases represent a form of Gitelman syndrome, and others may be another variant of hypokalemic metabolic alkalosis. In addition, hypomagnesemia does not reliably segregate to any of the three types of Bartter syndrome defined by molecular studies, suggesting that other circumstances may affect renal magnesium absorption. Supporting this notion is evidence that magnesium balance is normal in a Na ϩ -K ϩ -Cl Ϫ cotransport knockout mouse mimicking type I Bartter syndrome (323) . Chronic usage of furosemide is sometimes associated with hypomagnesemia due to excessive urinary magnesium excretion, but it is not universal (251) . Thus it is not apparent why most individuals with Na ϩ -K ϩ -Cl Ϫ cotransport defects should be comparatively free of renal magnesium wasting. It may be that the loop and distal tubule adapts to conserve magnesium in this disorder as it does for NaCl (156, 157, 190, 285) . Bartter syndrome typifies the serial control of magnesium conservation in the loop and distal tubule. Distal tubular function compensates for diminished loop absorption even though the hormonal controls are similar in the two nephron segments.
Gitelman syndrome
Patients with Gitelman syndrome are not polyuric or polydipsic but have hypocalciuria and usually show renal magnesium wasting (236) . They often present in late childhood with a hypokalemic metabolic alkalosis and low serum magnesium, which may be asymptomatic or may be severe enough to cause hypomagnesemic tetany (27, 158, 173) . Patients with Gitelman syndrome fail to respond to chlorothiazide, leading to the prediction that the renal defect is in the DCT (26, 62, 214, 320). Simon et al. (309) have shown that Gitelman syndrome families are genetically linked to a locus at 16q13 and identified causative mutations in the chlorothiazide-sensitive NaCl cotransporter expressed in the DCT (Fig. 16) (309) . There have now been over 82 distinct mutations that are associated with Gitelman syndrome. Nearly all of these mutations are nonconservative and affect amino acids that have been conserved throughout evolution. Schulteis et al. (296) developed a mouse model of Gitelman syndrome by deleting the gene coding for the apical NaCl cotransporter of the DCT. These mice show all the cardinal features of Gitelman syndrome including renal calcium conservation and diminished serum magnesium concentrations presumably due to urinary magnesium wasting, although the latter was not directly determined in this study. Because chlorothiazide enhances calcium reabsorption in the DCT, the hypocalciuria of Gitelman syndrome is readily explained (278) . The reasons for renal magnesium wasting are unknown (251) .
Some of the features of Gitelman syndrome may be observed in patients chronically receiving thiazide diuretics raising the possibility that loss in Na ϩ -Cl Ϫ cotransport could result in this disease. Although renal magnesium wasting and hypomagnesemia in Gitelman patients remain to be explained, a number of mechanisms may be invoked. We have shown that cellular potassium depletion diminishes Mg 2ϩ uptake in MDCT cells (70, see below). However, potassium deficiency is not always asso- (263) have postulated another way to explain magnesium wasting of Gitelman's patients (263) . They suggest that the absence of claudin 16 expression may somehow allow magnesium secretion via the paracellular pathway. The notion is that Gitelman syndrome converts some DCT cells that are predominantly electroneutral cells to cells that reabsorb Na ϩ in an electrogenic manner. As discussed by these authors, the cells are also responsive to the actions of aldosterone. Accordingly, the combination of the dominance of electrogenic ion transport pathways, the stimulation by aldosterone, and the increased Na ϩ concentration all favor electrogenic Na ϩ reabsorption. This greatly increases the magnitude of the transepithelial voltage that drives magnesium secretion. We do not favor this explanation because our earlier micropuncture studies failed to detect any secretion of Mg 2ϩ in microperfused distal tubules (246, 254) . Furthermore, perfusion of superficial distal tubules of hypermagnesemia rats with solutions containing sodium sulfate to elevate the transepithelial voltage failed to elicit luminal Mg 2ϩ entry (247) . Finally, claudin 16 is thought to be involved with enhancing Mg 2ϩ and Ca 2ϩ permeability in the thick ascending limb; accordingly, it is not evident that the aberrant or absent protein expression would increase permeability, thereby increasing Mg 2ϩ back-flux or secretion. As an alternative explanation, Kaissling et al. (156) have reported that complete block of NaCl entry with thiazide treatment results in apoptosis of rat DCT (156) . The Na ϩ -Cl Ϫ cotransporter knockout mice of Schultheis et al. (296) also demonstrated a decrease in number, height, and basolateral infolding of DCT cells. The mitochondria was less well developed in the homozygous null mice compared with the heterozygotes. Additionally, acute interstitial nephritis has been observed in human subjects chronically using thiazide diuretics (193) . It is postulated that inhibition of Na ϩ entry leads to increased intracellular Ca 2ϩ and impaired volume regulation with a decrease in DNA synthesis leading to apoptosis and tubule atrophy (188, 189) . Whether diminished cell surface is sufficient to jeopardize magnesium reabsorption within this segment is unknown, but this is a testable tenant in isolated DCT cells.
B. Inherited Disorders Associated With Abnormal Extracellular Mg
2؉
/Ca 2؉ Sensing
The Ca 2ϩ /Mg 2ϩ -sensing receptor plays an important role in controlling calcium and magnesium transport in both the loop and the distal tubule (20, 136). Both inactivating and activating mutations of the Ca 2ϩ /Mg 2ϩ -sensing receptor have been described that are now well characterized (241) . These abnormalities of Ca 2ϩ /Mg 2ϩ sensing are not selective for magnesium because calcium is also similarly affected (Table 3 ).
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
Familial hypocalciuric hypercalcemia (FHH) (9, 169, 175, 201) and neonatal severe hyperparathyroidism (NSHP) are conditions resulting from inactivating heterozygous and homozygous mutations, respectively (240 -242) . Renal excretion of calcium and magnesium is reduced leading to hypercalcemia and sometimes hypermagnesemia (9, 169, 175, 201) . Defective extracellular Ca 2ϩ /Mg 2ϩ sensing likely leads to inappropriate absorption of calcium and magnesium in both the thick ascending limb (136, 336) /Mg 2ϩ -sensing receptor knockout mouse that displays many of the characteristics of FHH and NSHPT patients. Homozygous mutant mice had elevated serum calcium and PTH concentrations but modest elevations of serum magnesium. The urinary concentration of calcium was inappropriately low given the marked elevations in serum calcium levels; urinary magnesium was not reported. Careful clearance studies are warranted to establish renal magnesium wasting because these animals are dehydrated and underweight. The homozygous mice also had severe skeletal abnormalities compared with the heterozygous or control animals (145).
Autosomal dominant hypoparathyroidism
Activating mutations termed autosomal dominant hypoparathyroidism (ADH) are dominant and present clinically as isolated hypocalcemic hypoparathyroidism. Hypomagnesemia may be observed in up to 50% of the patients (227, 234) . The mutant parathyroid and kidney Ca 2ϩ /Mg 2ϩ -sensing receptor has a lower set point for plasma Ca 2ϩ and Mg 2ϩ concentrations so that for any given divalent cation concentration PTH secretion and renal calcium transport are suppressed. The hypomagnesemia is usually asymptomatic, but significant deficiencies have been reported (227) . Some of this variability is due to the heterogeneity of the activating mutations and a corresponding variability in the set-point detection limit for serum Ca 2ϩ and Mg 2ϩ concentrations.
C. Primary Inherited Disorders of Distal
Hypomagnesemia with secondary hypocalcemia
Hypomagnesemia with secondary hypocalcemia (HSH) is an autosomal recessive disorder that manifests in the newborn period and is characterized by very low serum magnesium and low calcium concentrations (1, 58, 127, 233, 244, 279) . Patients usually present before 6 mo of age with neurological symptoms of hypomagnesemia and hypocalcemia, including tetany, muscle spasms, and seizures (54, 88). In older children with inadequate control, clouded sensorium and disturbed speech are often seen, and choreoathetoid movements have been described. The hypocalcemia is secondary to parathyroid failure (7, 318) and peripheral PTH resistance as a result of magnesium deficiency (314) . Hypokalemia is occasionally present that is only corrected with normalization of plasma magnesium (314) . The disease is primarily due to defective intestinal magnesium absorption and may be fatal unless treated with high oral intakes (43, 225, 232, 245, 300, 310, 315). Walder et al. (335) reported that HSH is an autosomal recessive disease and showed by genetic linkage studies that the gene segregates to chromosomes 9 (9q12-9q22.2). They suggest that the candidate gene codes a receptor or an ion channel involved in active intestinal magnesium absorption (335) . Because passive intestinal transport is normal, the disease can be treated by high oral magnesium supplements. Renal magnesium conservation has been reported to be normal in most studies, suggesting that the kidney responds appropriately to low circulating magnesium levels by reabsorbing fractionally greater amounts of filtered magnesium. In some cases, however, a renal leak may also be present that manifests primarily when oral supplements are insufficient to normalize the serum magnesium (207) . We speculate that the renal leak may be due to altered Mg 2ϩ entry into DCT cells. Whether this condition is genetically heterogeneous remains to be seen, but further studies to address renal tubular magnesium absorption as a function of plasma concentration and filtered magnesium in patients with well-delineated intestinal defects are clearly warranted.
Infantile isolated renal magnesium loss
Hypomagnesemia due to late-onset isolated renal magnesium loss is an autosomal dominant condition associated with few symptoms other than chondrocalcinosis (121) . Patients always have hypocalciuria and variable, but usually mild, hypomagnesemic symptoms. Meij et al. (210) have reported that the disorder maps to chromosome 11q23 in two large Dutch families. Database searches of the linkage region have so far failed to identify candidate genes, but Meij et al. (210) speculate from our experimental studies (251) that the mutation may lie in the distal tubule. Additionally, there is evidence for a variant form hypomagnesemia due to infantile isolated renal magnesium loss that is more consistent with autosomal recessive inheritance. Meij et al.
(personal communication) excluded linkage to any of the known loci previously reported indicating a novel disease. The patients also have variable symptoms, but they usually have normal urinary calcium excretion (104, 120) . Because the epithelial transporters of magnesium have not been delineated, it is unclear at what level the tubule magnesium absorption is affected.
Clinical observations suggesting both dominant and recessive inheritance argue for a number of familial renal wasting diseases. As the distal tubule reabsorbs 10 -15% of the filtered magnesium (80 -95% of that delivered to it), one would expect that if the primary reabsorptive channel were affected, then renal magnesium conservation would be severely compromised leading to marked hypomagnesemia. Alternatively, there may be separate magnesium transporters within the distal tubule under separate genetic control. This is a fertile ground for further genetic studies.
Experimental genetic studies
In addition to clinical investigations, experimental studies are being used to define the genetic basis of magnesium homeostasis. Henrotte and colleagues (138 -141) established inbred lines of mice by selecting for high and low plasma magnesium levels. Mice of the hypomagnesemic line have inappropriately high urinary magnesium excretion relative to serum levels (142) . The hypomagnesemic, hypermagnesiuric mice have normal calcium homeostasis, suggesting a selective tubular defect of magnesium reabsorption. Genetic analysis of these mice indicated that both histocompatibility (H2) related and H2 unrelated to loci were significant determinants of extracellular and intracellular magnesium content in the mice (142) . These mice are being used by Andre Mazur, Unite Maladies Metaboliques et Micronutriments, Theix, France, to genotype quantitative traits associated with renal magnesium wasting (personal communication). Studies such as these will be useful in explaining the clinical observations.
X. ACQUIRED DISORDERS THAT DIMINISH DISTAL MAGNESIUM TRANSPORT
A. Potassium Depletion
The relationship of cellular potassium and magnesium metabolism is complex and far from understood. Potassium depletion sometimes results in increased urinary magnesium and calcium excretion (87, 154, 179, 348) . The increase in urinary excretion of divalent cations may be explained by the known effects of potassium depletion on the thick ascending limb of the loop. Chloride conservation is impaired in potassium-depleted rats, which may be related to altered basolateral transport resulting in diminished NaCl transport (187) . To date, there is no direct evidence for changes in magnesium absorption in the thick ascending limb with potassium depletion. Because magnesium and calcium are absorbed by passive mechanisms, dependent on NaCl transport, it is probable that impaired NaCl transport may lead to diminished divalent cation absorption in this segment (249, 289) . Our studies, using isolated MDCT cells, however, suggest that potassium depletion may have important effects on magnesium transport within the DCT (Fig. 17) . MDCT cells were cultured in low potassium, 2.5 mM, for 16 h before determination of Mg 2ϩ uptake (70). Cellular potassium depletion (89 Ϯ 5 mM vs. control 126 Ϯ 6 mM) resulted in diminished Mg 2ϩ uptake as determined by microfluorescence. The cellular mechanisms for the decrease in Mg 2ϩ entry with potassium depletion are not known.
The interrelationships of plasma potassium and magnesium have clinically important ramifications but remain unexplained. As reviewed by Agus (2), hypokalemia is commonly associated with hypomagnesemia. The hypokalemia in these patients is difficult to correct with potassium supplementation alone but rapidly responds following correction of the magnesium deficit (341) . Intracellular Mg 2ϩ activates or rectifies many K ϩ channels leading to the speculation that magnesium depletion may alter potassium reabsorption or potassium secretion within the distal nephron. It is unlikely that cellular Mg 2ϩ would fall sufficiently to diminish Mg-ATP levels so that luminal ATP-regulated K ϩ channels are probably not involved (2) . Again, this notion would appear to be testable in isolated distal tubule cells.
B. Phosphate Depletion
One of the hallmarks of phosphate depletion is the striking increase in urinary excretion of calcium and magnesium (202) . Magnesium excretion may be sufficiently large to lead to overt hypomagnesemia. The increase in divalent ion excretion in both human and experimental animals occurs within hours after initiation of dietary phosphate restriction. It is evident from clearance experiments that the urinary excretion of divalent cations of phosphate-depleted subjects is inappropriate for the plasma concentration, supporting the notion of defective tubular transport (60). Using micropuncture, we have demonstrated that defective magnesium absorption occurred in the loop of Henle and the distal tubule of phosphate-depleted dogs (347) .
We have also shown that cellular phosphate depletion leads to diminished Mg 2ϩ uptake in MDCT cells (71). This observation supports the notion that the DCT may be involved, in part, in decreased magnesium absorption and increased magnesium excretion observed with phosphate depletion. The effects of phosphate depletion on Mg 2ϩ uptake in MDCT cells are reminiscent of those observed in the intact kidney. Removal of phosphate from the media rapidly leads to diminished Mg 2ϩ transport, which is dependent on the degree of phosphate depletion. Mg 2ϩ uptake is inhibited by 50% when cultured in ϳ0.3 mM phosphate. These actions are fully reversible with the return of phosphate to the media. The induction of defective transport that is associated with phosphate depletion must reside within the cell either to prevent the normal upregulation of Mg 2ϩ transport with Mg 2ϩ deficiency or to inhibit Mg 2ϩ uptake through actions on transport processes. To determine if phosphate depletion acts through posttranslational mechanisms, MDCT cells were first Mg 2ϩ depleted for 16 h to maximally upregulate Mg 2ϩ transport. The cells were then phosphate depleted for various time periods, and Mg 2ϩ uptake was assessed by microfluorescence (Fig. 18) . Phosphate deple- FIG. 17. Schematic model of inherited disorders of magnesium absorption in the distal convoluted tubule. The cellular mechanisms of phosphate depletion, potassium depletion, cyclosporin, and cisplatin are not known, but the evidence suggests that they affect intracellular regulatory processes rather than direct effects on Mg 2ϩ channels or the Ca 2ϩ /Mg 2ϩ sensing.
tion resulted in diminished Mg 2ϩ uptake in preadapted cells, which suggests it affects transport through actions on preformed pathways rather than through transcriptional or translational mechanisms. Further studies are necessary to define these posttranslational events. Interestingly, phosphate depletion is associated with diminished expression of the MRG described above (258) . Again, the role of MRG in magnesium reabsorption requires further work to clarify our understanding of control of cellular transport. It is evident from these studies with isolated MDCT cells that magnesium wasting commonly observed in hypophosphatemia and phosphate depletion could be due, in part, to diminished Mg 2ϩ uptake in the DCT.
C. Acid-Base Changes
It has long been known that systemic acidosis is associated with renal magnesium wasting (34, 180, 200) . Acute metabolic acidosis produced by infusion of NH 4 Cl or HCl leads to significant increases in urinary magnesium excretion (179, 200) . Chronic acidosis also leads to urinary magnesium wasting which, as with acute acidosis, may be partially corrected by the administration of bicarbonate (181, 235) . In contrast to metabolic acidosis, acute and chronic metabolic alkalosis consistently leads to a fall in urinary magnesium excretion (346) .
Although it has long been known that metabolic acidosis and alkalosis alter renal magnesium handling, relatively little information is available regarding the tubular segments involved. Wong et al. (344) showed that metabolic alkalosis resulted in increased magnesium reabsorption in the distal tubule of the dog. Magnesium reabsorption was closely associated with bicarbonate delivery to the distal tubule in this study. We have shown that acute bicarbonate infusions into chronic acidotic rats lead to a marked increase in magnesium reabsorption in the loop of Henle and distal tubule (301) . Thus, on balance, the evidence is that metabolic acidosis and alkalosis act on the distal tubule to change renal magnesium conservation.
We have used the MDCT cell line to determine the direct effects of proton changes on cellular Mg 2ϩ uptake (72). Unlike previous reports, this approach has the advantages of isolating the direct cellular effects of H ϩ on Mg 2ϩ transport in a controlled fashion that is independent of extrarenal influences. Poorly controlled diabetes mellitus is often associated with metabolic acidosis. Hypomagnesemia has been reported in ϳ25% of diabetic patients, and renal magnesium wasting has been associated with both type I and type II diabetes mellitus (152, 162) . Because insulin stimulates magnesium conservation in the loop (195) and distal tubule (68), insulin deficiency could explain the increase in urinary magnesium excretion. A number of indirect influences commonly present in diabetes mellitus may also explain an increase in magnesium excretion. First, uncontrolled hyperglycemia and hyperglycuria may increase excretion through osmotic diuresis (251) . Second, metabolic acidosis commonly observed in diabetes may increase magnesium excretion by its actions within the distal tubule (251) . Finally, hypophosphatemia and hypokalemia are often associated with diabetes; both may decrease distal magnesium reabsorption (152) . Acidosis with any one of these entities may underlie the diminished magnesium reabsorption and hypomagnesemia commonly observed in diabetes mellitus.
D. Cytotoxic Agents
The use of a number of antibiotics, tuberculostatics, and antiviral drugs (3, 158, 299) may be associated with FIG. 18. Phosphate depletion inhibits Mg 2ϩ uptake in MDCT cells preadapted to low magnesium. MDCT cells were cultured in zero magnesium, normal phosphate media for 16 h and for another 16 h in either zero phosphate or 1.0 mM phosphate in addition to zero magnesium. Mg 2ϩ uptake was assessed in both cell populations according to the methods given in Fig. 1 renal magnesium wasting (Table 4 ). The cellular basis by which some of these agents lead to diminished magnesium transport has recently become clear, but others remain unexplained. Many are associated with general cellular toxicity and associated electrolyte abnormalities, but it is of interest that some are relatively selective for magnesium.
Cisplatin
Treatment with the cancer antimetabolite cisplatin commonly results in renal magnesium wasting and hypomagnesemia (3, 158, 299) . The incidence of magnesium deficiency is Ͼ30% but increases to Ͼ70% with longer cisplatin usage and greater accumulated doses. Interestingly, cisplatin-induced magnesium wasting is relatively selective (25). Hypocalcemia and hypokalemia may be observed but only with prolonged and severe magnesium deficiency (125, 191, 198, 209, 321) . The influence of magnesium deficiency on PTH secretion and end-organ resistance is the likely explanation for enhanced urinary calcium excretion and diminished mobilization resulting in low plasma calcium concentrations (7, 96) . The effects on potassium balance are more difficult to explain. The hypokalemia observed with magnesium deficiency is refractory to potassium supplementation (275) . Cisplatin results in proximal tubular damage, but the evidence from both clinical and experimental studies indicates that the drug acts on distal tubular magnesium transport (194, 209, 322) . Because there is no magnesium reabsorption within the CCD, it is likely that actions within the DCT are responsible for the renal magnesium leak. Using micropuncture, Mavichak et al. (209) showed that magnesium reabsorption was diminished in the distal tubule of rats receiving cisplatin. The cellular mechanisms for the apparent selective effects on magnesium remain undefined. It would be of interest to determine if amiloride retains its magnesium-conserving actions in these patients (251) . The effects of cisplatin may persist months or years later, long after the inorganic platinum has disappeared from the renal tissue (199, 334) . Whatever cellular mechanisms are involved, it must include genetic alteration of magnesium transport. The fact that cisplatin exerts its therapeutic effects by binding cellular DNA may be relevant (294).
Aminoglycosides
Aminoglycosides, such as gentamicin, cause hypermagnesiuria and hypomagnesemia (Table 4) . As many as 25% of patients receiving gentamicin will present with hypomagnesemia (299) . The hypermagnesiuric response occurs soon after the onset of therapy; it is dose dependent and readily reversible upon withdrawal (94, 122, 230, 237) . Hypokalemia is frequently observed with the magnesium deficiency. Magnesium wasting is associated with hypercalciuria that may lead to diminished plasma calcium concentrations (94, 161) . This would suggest that aminoglycosides affect renal magnesium and calcium transport in the tubular segments where both are reabsorbed, namely, the thick ascending limb and the DCT. Experimental studies with animals support this notion (4, 103, 112, 231) . The cellular mechanisms are unknown, but hypermagnesiuria and hypercalciuria are observed in the absence of histopathological changes (337) . Gentamicin is a polyvalent cation so that it may have its effects on the Ca 2ϩ /Mg 2ϩ -sensing receptor. Activation of this receptor by polyvalent cations inhibits passive absorption of magnesium and calcium in the loop and active hormonemediated transport in the DCT (20, 21, 136). In support of this notion, we have shown that gentamicin inhibits PTHmediated cAMP formation and PTH-stimulated Mg 2ϩ uptake in MDCT cells (159) . The inhibition was concentration dependent and reversed by the application of high concentrations of 8-bromo-cAMP or forskolin. We infer from these studies that gentamicin inhibits hormone-stimulated Mg 2ϩ absorption in the DCT that contributes to renal magnesium wasting, which is frequently observed with the clinical use of aminoglycosides.
Cyclosporin and FK506
The immunosuppressants, cyclosporin and FK506, commonly lead to renal magnesium wasting and hypomagnesemia (23, 171, 273) . Unlike the other agents, these drugs usually cause a significant reduction in glomerular filtration rate (GFR) (up to 60%) and modest hypercalcemia and hypokalemia (273) . The hypomagnesemic effect is probably attenuated by the fall in GFR and reduction in filtered magnesium, but this defect appears to be specific for magnesium (260, 274, 343) . The distal tubule is probably the site of the tubular magnesium leak. It is not known whether these drugs act through calcineurin, which is the intracellular receptor for these agents. 
XI. SUMMARY: FUTURE DIRECTIONS IN RESEARCH OF MAGNESIUM TRANSPORT IN THE DISTAL CONVOLUTED TUBULE
Although the majority of filtered magnesium is reabsorbed in the thick ascending of the loop of Henle, it is apparent that the distal tubule also participates in the sensitive and selective control of renal magnesium handling. It also serves an important site for familial and acquired magnesium wasting disorders. As with other cations, such as sodium, potassium, and calcium, the distal tubule plays a significant role in control of daily electrolyte balance and perhaps more importantly in homeostasis over a long period of time. The DCT may reabsorb a minor fraction of filtered salt, but it provides an additional regulation that is serially posed to act in concert with the other nephron segments to affect electrolyte homeostasis. The aim of this review has been to review our current understanding of magnesium handling by the distal tubule and to integrate these observations into the overall renal control of magnesium. Like other cations, the reabsorptive rate of magnesium in the distal tubule is load dependent; that is, absolute magnesium absorption increases with enhanced delivery to this segment. This association is valid whether magnesium delivery is altered either by an increase in tubule fluid magnesium concentration or by an increase in fluid flow rate issuing from the loop of Henle. Transepithelial magnesium absorption is active in the distal tubule as transport is against luminal-to-interstitial electrical and concentration gradients. The evidence is that Mg 2ϩ moves across the apical membrane dependent on the transmembrane concentration and down a favorable electrical gradient. Accordingly, this transport is passive and likely through a selective Mg 2ϩ channel. The mechanism whereby Mg 2ϩ exits across the basolateral membrane into the interstitium is unknown but must be active. The rate-limiting step and the site of regulation appears to occur with the entry of Mg 2ϩ into the DCT cell. The peptide hormones, PTH, calcitonin, glucagon, and AVP, increase Mg 2ϩ transport in the distal tubule through cAMP-, phospholipase C-, and protein kinase C-mediated signaling pathways. PGE 2 -sensing mechanism. Selective control of Mg 2ϩ uptake and absorption appears to occur after magnesium restriction. Our evidence suggests that this is through an increase in selective Mg 2ϩ transport, in part, by transcriptional-translational processes involving de novo protein synthesis. Adaptation to magnesium restriction is observed at both the organ and cellular levels. The mechanisms used by the DCT cell to sense the extracellular Mg 2ϩ concentration and appropriately adapt the transport rates are fertile areas for future research. Mg 2ϩ uptake may also be modulated by a number of posttranslational events. Amiloride and chlorothiazide are magnesium-conserving diuretics by virtue of their ability to stimulate voltage-sensitive Mg 2ϩ entry in DCT cells. A number of inherited diseases affect magnesium transport within the DCT. These include those associated with abnormal NaCl absorption (Gitelman syndrome), extracellular Ca 2ϩ / Mg 2ϩ sensing (FHH and NSHPT), and primary magnesium wasting most likely affecting selective cellular Mg 2ϩ transport. Genetic studies are interesting because they describe nature's experiments in control of magnesium transport and lead to here-to-unforeseen transport possibilities. A large number of acquired disorders affect magnesium absorption in the DCT. Cellular potassium depletion diminishes Mg 2ϩ transport through undefined ways. As marked increases in Mg 2ϩ concentration or hyperpolarization do not normalize transport, it is probable that the effect of potassium depletion is on the magnesium transporter. Similarly, cellular phosphate depletion decreases Mg 2ϩ uptake in MDCT cells. Again, the mechanisms are not known but must be posttranslational because removal of phosphate rapidly leads to diminished Mg 2ϩ uptake in cells that have previously been fully adapted. Both of these conditions, potassium and phosphate depletion, lead not only to diminished Mg 2ϩ uptake in the DCT but to renal magnesium wasting, supporting the notion that the defect in DCT transport provides the basis for these diseases. Our studies suggest that cellular potassium and phosphate depletion act through different mechanisms. Acid-base changes alter cellular Mg 2ϩ uptake and renal magnesium reabsorption. These changes are due to direct effects of protons on Mg 2ϩ transport and are independent of alterations in membrane voltage and modulations due to potassium and phosphate depletion. Again, metabolic alkalosis or acidosis may play a significant role in dictating the control of renal magnesium handling. Magnesium wasting and hypomagnesemia are common observations in metabolic acidotic patients. Because these three entities, potassium depletion, hypophosphatemia, and metabolic acidosis, act at different sites along the Mg 2ϩ transport pathway, they may exacerbate renal magnesium wasting when present in combination. Finally, various drugs including antibiotics, antitumor agents, and immunosuppressants may affect magnesium handling out of proportion to other electrolytes. 
